Indirect Comparisons of the Efficacy of Subcutaneous Epcoritamab Vs Chemoimmunotherapy in Patients with Relapsed or Refractory Large B-Cell Lymphoma

被引：0
|
作者：
Salles, Gilles [1 ]
Wang, Anthony [2 ]
Mutebi, Alex [3 ]
Alshreef, Abualbishr [2 ]
Davies, Kalatu R. [2 ]
van de Wetering, Gijs [4 ]
Chirikov, Viktor [4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] AbbVie Inc, N Chicago, IL USA
[3] Genmab, Princeton, NJ USA
[4] Open Hlth, Bethesda, MD USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158028
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10934 / 10935
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of lenalidomide in relapsed/refractory diffuse large B-cell lymphoma
    Habermann, T.
    Lossos, I.
    Justice, G.
    Tuscano, J.
    Cole, C.
    Vose, J.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J.
    Wiernik, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 150 - 150
  • [22] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [23] Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
    Nastoupil, Loretta J.
    Andersen, Clark R.
    Ayers, Amy
    Wang, Yucai
    Habermann, Thomas M.
    Chihara, Dai
    Kahl, Brad S.
    Link, Brian K.
    Koff, Jean L.
    Cohen, Jonathon B.
    Martin, Peter
    Lossos, Izidore S.
    Stanchina, Michele
    Haddadi, Sara
    Casulo, Carla
    Ayyappan, Sabarish
    Lin, Ruitao
    Li, Ziyi
    Larson, Melissa A.
    Maurer, Matthew J.
    Huynh, Lynn
    Gao, Chi
    Ramasubramanian, Ramya
    Duh, Mei Sheng
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Wang, Anthony
    Kamalakar, Rajesh
    Kalsekar, Anupama
    Cerhan, James R.
    Flowers, Christopher R.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (04):
  • [24] Tisagenlecleucel and Lisocabtagene Maraleucel: Comparative Efficacy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Zhang, Jie
    Yang, Hongbo
    Agarwal, Abhijit
    Tang, Wenxi
    Prieto, Marcela Martinez
    Bollu, Vamsi
    Kuzan, David
    Maziarz, Richard
    Kersten, Marie Jose
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S380 - S381
  • [25] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
    Hideki Goto
    Shinichi Makita
    Koji Kato
    Kota Tokushige
    Taizo Fujita
    Koichi Akashi
    Koji Izutsu
    Takanori Teshima
    International Journal of Clinical Oncology, 2020, 25 : 1736 - 1743
  • [26] Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Westin, Jason
    Maris, Michael B.
    Jacobson, Caron A.
    Patel, Prapti
    Lakhani, Nehal
    Harb, Wael
    Patel-Donnelly, Dipti
    McCaul, Kelly
    Escobar, Carolina
    Klencke, Barbara
    Al-Katib, Ayad M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01): : 52 - 59
  • [27] Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
    Arcari, Annalisa
    Chiappella, Annalisa
    Valenti, Vanessa
    Zanlari, Luca
    Tani, Monica
    Marasca, Roberto
    Cabras, Maria Giuseppina
    Spina, Michele
    Santagostino, Alberto
    Ilariucci, Fiorella
    Carli, Giuseppe
    Musto, Pellegrino
    Savini, Paolo
    Marino, Dario
    Ghio, Francesco
    Gentile, Massimo
    Cox, Maria Christina
    Della Seta, Roberta
    Vallisa, Daniele
    BLOOD, 2014, 124 (21)
  • [28] Efficacy and safety of lenalinomide combined with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma
    Ivanov, Vadim
    Coso, Diane
    Chetaille, Bruno
    Esterni, Benjamin
    Olive, Daniel
    Aurran-Schleinitz, Therese
    Schiano, Jean Marc
    Stoppa, Anne-Marie
    Broussais-Guillaumot, Florence
    Blaise, Didier
    Bouabdallah, Reda
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2508 - 2513
  • [29] Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma
    Goto, Hideki
    Makita, Shinichi
    Kato, Koji
    Tokushige, Kota
    Fujita, Taizo
    Akashi, Koichi
    Izutsu, Koji
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1736 - 1743
  • [30] Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma
    Maziarz, Richard T.
    Zhang, Jie
    Yang, Hongbo
    Chai, Xinglei
    Yuan, Chengbo
    Schwarz, Elisabeth
    Jakovac, Mihael
    Martinez-Prieto, Marcela
    Agarwal, Abhijit
    Degtyarev, Evgeny
    Tam, Constantine
    Salles, Gilles
    BLOOD ADVANCES, 2022, 6 (08) : 2536 - 2547
12345